Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela M Cirillo

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Scientific Reports|October 20, 2018
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebaseMatthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
Scientific Reports|February 22, 2020
Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebaseMatthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
BMJ Open|November 28, 2024
Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TBKogieleum Naidoo, Anushka Naidoo, Alash'le G Abimiku, et al.
American Journal of Respiratory and Critical Care Medicine|October 11, 2014
Risk assessment of tuberculosis in immunocompromised patients. A TBNET studyMartina Sester, Frank van Leth, Judith Bruchfeld, et al.
JCI Insight|April 19, 2022
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infectionRachel M Gittelman, Enrico Lavezzo, Thomas M Snyder, et al.
Open Forum Infectious Diseases|July 22, 2025
The Ethiopian Third National Tuberculosis Drug Resistance Survey Incorporating Whole Genome SequencingShewki Moga, Muluwork Getahun, Zemedu Mohammed, et al.
Wellcome Open Research|February 15, 2020
Antibiotic resistance prediction for <i>Mycobacterium tuberculosis</i> from genome sequence data with MykrobeMartin Hunt, Phelim Bradley, Simon Grandjean Lapierre, et al.
The Lancet. Infectious Diseases|December 5, 2017
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy studySusan E Dorman, Samuel G Schumacher, David Alland, et al.
The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
The Lancet. Infectious Diseases|March 8, 2025
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trialÁlvaro H Borges, Marisa Russell, Dereck Tait, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Scientific Reports|October 20, 2018
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebaseMatthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
Scientific Reports|February 22, 2020
Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebaseMatthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
BMJ Open|November 28, 2024
Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TBKogieleum Naidoo, Anushka Naidoo, Alash'le G Abimiku, et al.
American Journal of Respiratory and Critical Care Medicine|October 11, 2014
Risk assessment of tuberculosis in immunocompromised patients. A TBNET studyMartina Sester, Frank van Leth, Judith Bruchfeld, et al.
JCI Insight|April 19, 2022
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infectionRachel M Gittelman, Enrico Lavezzo, Thomas M Snyder, et al.
Open Forum Infectious Diseases|July 22, 2025
The Ethiopian Third National Tuberculosis Drug Resistance Survey Incorporating Whole Genome SequencingShewki Moga, Muluwork Getahun, Zemedu Mohammed, et al.
Wellcome Open Research|February 15, 2020
Antibiotic resistance prediction for <i>Mycobacterium tuberculosis</i> from genome sequence data with MykrobeMartin Hunt, Phelim Bradley, Simon Grandjean Lapierre, et al.
The Lancet. Infectious Diseases|December 5, 2017
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy studySusan E Dorman, Samuel G Schumacher, David Alland, et al.
The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
The Lancet. Infectious Diseases|March 8, 2025
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trialÁlvaro H Borges, Marisa Russell, Dereck Tait, et al.
Pageof 14